Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $278.80 | Total: $1,394.00 |
| 1 | 10 | $236.16 | Total: $2,361.60 |
| 1 | 25 | $200.08 | Total: $5,002.00 |
| 1 | 50 | $170.56 | Total: $8,528.00 |
| 1 | 100 | $147.60 | Total: $14,760.01 |
Overview
KFM19 is a potent and selective adenosine receptor (A1-receptor) antagonist (IC50 : 50 nM) for the study of neurological disorders.
Chemical Properties
| Molecular Formula | C16H22N4O3 |
| Molecular Weight | 318.37 |
| CAS Numbers | 133058-72-7 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCC(=O)C1 |
Storage and Handling
0C Short Term, -20C Long Term
References
W.D. Bechtel, et al. KFM 19 antagonizes the adenosine-induced inhibition of electrically evoked acetylcholine release. Eur Neuropsychopharmacol. Sep. 1993, 3[3], Page 433